Tamara Vokes to Vitamin D
This is a "connection" page, showing publications Tamara Vokes has written about Vitamin D.
Connection Strength
1.113
-
Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2021 03 01; 4(3):e214117.
Score: 0.144
-
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2020 09 01; 3(9):e2019722.
Score: 0.139
-
Quality of Life in Hypoparathyroidism. Endocrinol Metab Clin North Am. 2018 12; 47(4):855-864.
Score: 0.122
-
Quality of life in hypoparathyroidism. Bone. 2019 03; 120:542-547.
Score: 0.122
-
Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism. J Clin Endocrinol Metab. 2018 02 01; 103(2):722-731.
Score: 0.117
-
Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Endocrine. 2017 Jan; 55(1):273-282.
Score: 0.106
-
Ethnic Differences in Osteoporosis After Cardiac Transplantation. J Clin Densitom. 2017 Apr - Jun; 20(2):164-171.
Score: 0.106
-
rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes. Eur J Endocrinol. 2025 Jul 31; 193(2):310-319.
Score: 0.049
-
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. J Bone Miner Res. 2023 01; 38(1):14-25.
Score: 0.041
-
Management of Hypoparathyroidism. J Bone Miner Res. 2022 12; 37(12):2663-2677.
Score: 0.040
-
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2022 01 01; 107(1):e372-e385.
Score: 0.038
-
The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocr Disord. 2021 Nov 20; 21(1):232.
Score: 0.038
-
Hypoparathyroidism. Nat Rev Dis Primers. 2017 08 31; 3:17055.
Score: 0.028
-
Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013 Dec; 1(4):275-83.
Score: 0.022